Hainan Shuangcheng Pharmaceut
Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmace… Read more
Hainan Shuangcheng Pharmaceut (002693) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.083x
Based on the latest financial reports, Hainan Shuangcheng Pharmaceut (002693) has a cash flow conversion efficiency ratio of 0.083x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥33.67 Million) by net assets (CN¥404.35 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hainan Shuangcheng Pharmaceut - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Hainan Shuangcheng Pharmaceut's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hainan Shuangcheng Pharmaceut Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hainan Shuangcheng Pharmaceut ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Inflection Point Acquisition Corp. III Class A Ordinary Shares
NASDAQ:IPCX
|
-0.001x |
|
Okins Electronics Co. Ltd
KQ:080580
|
0.113x |
|
CFM Indosuez Wealth SA
PA:MLCFM
|
-1.211x |
|
GuangZhou Wahlap Technology Corporation Limited
SHE:301011
|
0.044x |
|
Asure Software Inc
NASDAQ:ASUR
|
0.030x |
|
Logistea AB Series B
ST:LOGI-B
|
0.003x |
|
TTK Prestige Limited
NSE:TTKPRESTIG
|
0.018x |
|
VT GMP Co.Ltd
KQ:018290
|
-0.043x |
Annual Cash Flow Conversion Efficiency for Hainan Shuangcheng Pharmaceut (2009–2024)
The table below shows the annual cash flow conversion efficiency of Hainan Shuangcheng Pharmaceut from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥411.61 Million | CN¥-40.83 Million | -0.099x | -541.12% |
| 2023-12-31 | CN¥517.65 Million | CN¥11.64 Million | 0.022x | -48.20% |
| 2022-12-31 | CN¥580.94 Million | CN¥25.22 Million | 0.043x | +4.45% |
| 2021-12-31 | CN¥566.75 Million | CN¥23.55 Million | 0.042x | +336.77% |
| 2020-12-31 | CN¥598.31 Million | CN¥-10.50 Million | -0.018x | -117.88% |
| 2019-12-31 | CN¥678.26 Million | CN¥66.58 Million | 0.098x | +40.36% |
| 2018-12-31 | CN¥669.69 Million | CN¥46.84 Million | 0.070x | +336.39% |
| 2017-12-31 | CN¥761.71 Million | CN¥-22.54 Million | -0.030x | -142.35% |
| 2016-12-31 | CN¥553.13 Million | CN¥38.65 Million | 0.070x | +40.17% |
| 2015-12-31 | CN¥927.61 Million | CN¥46.24 Million | 0.050x | -12.67% |
| 2014-12-31 | CN¥893.55 Million | CN¥51.00 Million | 0.057x | -11.95% |
| 2013-12-31 | CN¥870.62 Million | CN¥56.43 Million | 0.065x | -31.65% |
| 2012-12-31 | CN¥845.85 Million | CN¥80.22 Million | 0.095x | -67.23% |
| 2011-12-31 | CN¥228.23 Million | CN¥66.05 Million | 0.289x | -17.45% |
| 2010-12-31 | CN¥157.82 Million | CN¥55.33 Million | 0.351x | -38.27% |
| 2009-12-31 | CN¥77.95 Million | CN¥44.27 Million | 0.568x | -- |